Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Eli Lilly ( LLY 3.89%) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Josiah Ball scored 34 points, A.J. Kelly backed him with 20 points and Maconaquah breezed past Lewis Cass 72-34 in a Three ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

In Dubai, people with disabilities are lovingly referred to as "people with determination." This empowering term captures the essence of individuals who embody resolve and a firm sense of purpose ...

Eli Lilly reported mixed fourth-quarter results on Thursday, surpassing earnings expectations but falling short of sales projections, even as demand for its flagship weight loss drug Zepbound and ...

In a disheartening event that unfolded recently a Waymo robotaxi was vandalized outside of the Beverly Center in Los Angeles by a group of individuals. This act resulted in significant damage and ...

Deep-pocketed investors have adopted a bullish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

Gray (elbow) agreed to a one-year, $1.35 million contract with the Nationals on Thursday to avoid arbitration, Andrew Golden of The Washington Post reports. Gray underwent Tommy John surgery and ...

Eli Lilly spooked the market with warnings of a small revenue slowdown in Q4 2024. Lilly nevertheless delivered good news about its prospects for sales growth in 2025. The company also dropped a ...